APOE4 gene linked to early onset Alzheimer's, target for therapeutic intervention A study published in Nature Medicine delineates how APOE4 homozygosity distinctly accelerates Alzheimer's disease pathology and biomarkers from the age of 55, suggesting a unique form of the disease and a potential focus for targeted therapies.
https://www.news-medical.net/n....ews/20240508/APOE4-g